Page 24 - Cell Line Development News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Advances in Biopharma Digitalization Presented at the 7th Annual Genedata Partner Symposium Share Article Leading scientific, IT and business innovators in the biopharma industry discussed new R&D trends, with a focus on cell & gene therapies, and shared how they use the Genedata Biopharma platform to automate and digitalize their R&D workflows Genedata In addition to the excellent presentations, the many demo sessions and the chance to talk to other participants about their experiences when onboarding an enterprise end-to-end solution made the event extremely interesting and productive. ...

Asher Biotherapeutics Contracts ProBioGen to Develop and Manufacture Their Lead Candidate   BERLIN, Germany, April 26, 2021 / B3C newswire / --ProBioGen AG today announced that Asher Biotherapeutics, Inc., has entered into a service agreement covering all aspects of cell line development, process development and GMP manufacturing at 1000 L bioreactor scale. ProBioGen will now advance the development of Asher's lead candidate in immuno-oncology applying its unique transposase technology DirectedLuck™ which greatly accelerates time-to-clinic. Asher Biotherapeutics, a ...

Share this article Share this article ResearchAndMarkets.com's offering. The global single cell technology (SCT) market has emerged since 2014. There are over 43 companies with various 49 SCT products commercialized worldwide, and over 15 pre-commerce-stage startups are lined up and keep increasing. The market size is over $800 M in 2019, at a CAGR of ~24%. The market is expected to grow significantly by the growing awareness of the single cell projects among biology communities, the growth of precision medicine and diagnostic industry, the antibody therapeutic drug development, the entry of...

Hybridomas Segment to Register Highest CAGR in Cell Line Development Market during 2020-2027 The market was valued at US$ 4,160.42 million in 2019 and is projected to reach US$ 11,219.87 million by 2027; it is expected to grow at a CAGR of 13.3% from 2020 to 2027 The global cell line development market, based on type, is segmented into primary cell line, hybridomas, continuous cell lines, and recombinant cell lines. The recombinant cell lines segment held the largest share of the market in 2019. This growth is ascribed to the increasing demand for recombinant cell lines in the production of t...

Bio Process Technology Market Insights: Growth Factors, Market Drivers, Segmentations, Key Players, Analysis & Forecast by 2023